TCT 537: Optimization of Access Using Dedicated RF-TSP Devices Increases Efficiency and Consistency of LAAC With WATCHMAN FLX Pro: A Report From HEAL-LAA Primary Analysis Subset
Presenter:
We Recommend
Disclosures
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
- Grant Support/Research Contract - Boston Scientific Corporation; Medtronic
- Consultant Fee/Honoraria/Speaker's Bureau - Biosense Webster; Abbott